anti-CD137 Pb-Tx

N/A

Report date: 2025/01/26 18:09:58

Base Information

Drug Nameanti-CD137 Pb-Tx
Drug Alias Nameanti-CD137 costimulator prodrug (Cytomx Therapeutics)1D8 Probody therapeuticanti-CD137 probody (Cytomx Therapeutics)4-1BB costimulator prodrug (Cytomx Therapeutics)
ClassificationBiologics
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 stimulants
TargetsTumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCytomx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCytomx Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A